Found 31 matching trials
Treatment of CD79B Mutant Relapsed/Refractory Diffuse Large B-Cell Lymphoma With Bruton Tyrosine Kinase Inhibitor Zanubrutinib PHASE2 The goal of this clinical trial was to evaluate whether zanubrutinib can ef...
Show More Location
Anhui Provincial Cancer Hospital Aka West Branch of Anhui Province Hospital
Learn More & Join Trial
Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment PHASE2 The primary objective of this study is to evaluate the safety of zanubrutin...
Show More Location
Rocky Mountain Cancer Centers (Williams) Usor
Learn More & Join Trial
Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies PHASE1 The primary objective of this study was to assess the steady-state zanubrut...
Show More Location
Concord Repatriation General Hospital
Learn More & Join Trial
A Pharmacokinetic Study to Assess Drug-drug Interaction Between Zanubrutinib and a Cocktail of Substrates in Healthy Subjects PHASE1 This study is designed to evaluate the safety and pharmacokinetic interacti...
Show More Location
Covance Clinical Research Unit
Learn More & Join Trial
Study of BTK Inhibitor Zanubrutinib in Participants With Relapsed/Refractory Non-GCB Type Diffuse Large B Cell Lymphoma PHASE2 Screening (up to 28 days); daily treatment until disease progression, unacc...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
ZR2 Followed by Immunochemotherapy in Elderly Patients With Newly-diagnosed DLBCL PHASE2 As the most common subtype of lymphoma, diffuse large B-cell lymphoma (DLBC...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
MRD Guided Sonrotoclax and Zanubrutinib in Newly Diagnosed CLL/SLL PHASE2 This is a single-arm, open-label study of sonrotoclax plus zanubrutinib wit...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Bcl-2 Inhibitor Sonrotoclax (BGB-11417) in Participants With Mature B-Cell Malignancies PHASE1 The purpose of this study is to determine the safety, tolerability; and to ...
Show More Status
Active Not Recruiting
Location
UCLA Hematologyoncology
Learn More & Join Trial
Testing Mosunetuzumab Alone, With Zanubrutinib, or With Polatuzumab Vedotin for Treating Marginal Zone Lymphoma That Came Back or Didn't Get Better With Treatment PHASE2 This phase II trial compares the effect of mosunetuzumab alone to mosunetuz...
Show More Location
Multiple Locations
Learn More & Join Trial
Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia N/A This is a hybrid (retrospective and prospective) non-interventional registr...
Show More Location
Clearview Cancer Institute
Learn More & Join Trial